Senior insider sale
ENLIVEN THERAPEUTICS, INC. — senior position signals high conviction
$11.54M
272.32K shares
What this filing means
ORBIMED ADVISORS LLC plans to sell 272.32K shares of ENLIVEN THERAPEUTICS, INC. valued at approximately $11.54M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/16/2026ACC: 0000947871-26-000628
Director10% Owner
Since Mar 2020
272.32K
Shares to sell
$11.54M
Approx. market value
272.32K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Merger
N/A
2/23/2023
272.32KTotal acquired272.32K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/23/2023 | Merger N/A | 272.32K | — |
| Total | 272.32K | ||
Planned & Completed Dispositions1
Nasdaq Stock MarketPlanned
Units to sell
272.32K
Market value
$11.54M
6/15/2026
Total
Units
272.32K
Value
$11.54M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/15/2026 | 272.32K | $11.54M | Nasdaq Stock Market | Planned |
| Total | 272.32K | $11.54M | ||